LakeShore Biopharma Co Net Income
| LSBDelisted Stock | 0.63 0.00 0.00% |
As of the 12th of February 2026, LakeShore Biopharma secures the Risk Adjusted Performance of (0.27), mean deviation of 5.27, and Standard Deviation of 8.64. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of LakeShore Biopharma, as well as the relationship between them.
LakeShore Biopharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing LakeShore Biopharma's valuation are provided below:LakeShore Biopharma Co does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. LakeShore |
Search Suggestions
| L | Loews Corp | Company |
| LANDP | Gladstone Land | Company |
| LDP | Cohen Steers Limited | Fund |
| LD | Barclays Capital | ETF |
| LOWN | NYSE New Lows | Index |
| LA | Lagrange | Cryptocurrency |
| L626A6AA2 | MCBRAC 725 30 JUN 31 | Corporate Bond |
| LBUSD | Lumber Futures | Commodity |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, LakeShore Biopharma Co reported net income of (99.98 Million). This is 129.3% lower than that of the Biotechnology sector and 242.74% lower than that of the Health Care industry. The net income for all United States stocks is 117.51% higher than that of the company.
LakeShore Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LakeShore Biopharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LakeShore Biopharma could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics of similar companies.LakeShore Biopharma is currently under evaluation in net income category among its peers.
LakeShore Fundamentals
| Return On Equity | -0.18 | |||
| Return On Asset | -0.0215 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.69) % | |||
| Current Valuation | 88.96 M | |||
| Shares Outstanding | 41.21 M | |||
| Shares Owned By Insiders | 87.54 % | |||
| Shares Owned By Institutions | 0.79 % | |||
| Number Of Shares Shorted | 36.99 K | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 0.04 X | |||
| Revenue | 614.96 M | |||
| Gross Profit | 507.19 M | |||
| EBITDA | (48.54 M) | |||
| Net Income | (99.98 M) | |||
| Total Debt | 414.4 M | |||
| Book Value Per Share | 24.07 X | |||
| Cash Flow From Operations | (120.98 M) | |||
| Short Ratio | 0.55 X | |||
| Earnings Per Share | (0.73) X | |||
| Target Price | 4.19 | |||
| Number Of Employees | 758 | |||
| Beta | 0.57 | |||
| Market Capitalization | 25.84 M | |||
| Total Asset | 1.37 B | |||
| Retained Earnings | (2.41 B) | |||
| Working Capital | 17.47 M | |||
| Net Asset | 1.37 B |
About LakeShore Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LakeShore Biopharma Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LakeShore Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LakeShore Biopharma Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in LakeShore Stock
If you are still planning to invest in LakeShore Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LakeShore Biopharma's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |